Source: https://www.federalregister.gov/documents/2019/08/14/2019-17148/significant-new-use-rules-on-certain-chemical-substances-19-4b
Timestamp: 2019-08-25 02:28:39
Document Index: 352231849

Matched Legal Cases: ['art 707', 'art 707', 'art 721', 'art 721', '§\u2009721', '§\u2009721', '§\u2009721', '§\u2009721', '§\u2009721', '§\u2009721']

40371-40381 (11 pages)
FRL-9997-73
PMN Number: P-16-92
PMN Number: P-17-346
PMN Numbers: P-17-347, P-17-348, P-17-349, P-17-350, P-17-351 and P-17-352
PMN Number: P-17-395
PMN Number: P-18-35
PMN Number: P-18-103
PMN Numbers: P-18-155 and P-18-156
PMN Number: P-18-286
PMN Number: P-18-392
PMN Number: P-19-29
PMN Number: P-19-62
https://www.federalregister.gov/d/2019-17148 https://www.federalregister.gov/d/2019-17148
EPA is proposing significant new use rules (SNURs) under the Toxic Substances Control Act (TSCA) for 17 chemical substances which are the subject of premanufacture notices (PMNs). This action would require persons to notify EPA at least 90 days before commencing manufacture (defined by statute to include import) or processing of any of these 17 chemical substances for an activity that is designated as a significant new use by this proposed rule. This action would further require that persons not commence manufacture or processing for the significant new use until they have submitted a Significant New Use Notice, and EPA has conducted a review of the notice, made an appropriate determination on the notice under TSCA 5(a)(3), and has taken any risk management actions as are required as a result of that determination.
Submit your comments, identified by docket identification (ID) number EPA-HQ-OPPT-2019-0442, by one of the following methods:
You may be potentially affected by this action if you manufacture (including import), process, or use the Start Printed Page 40372chemical substances contained in this proposed rule. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include:
This action may also affect certain entities through pre-existing import certification and export notification rules under TSCA. Chemical importers are subject to the TSCA section 13 (15 U.S.C. 2612) import certification requirements promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical importers must certify that the shipment of the chemical substance complies with all applicable rules and orders under TSCA. Importers of chemicals subject to these proposed SNURs would need to certify their compliance with the SNUR requirements should these proposed rules be finalized. The EPA policy in support of import certification appears at 40 CFR part 707, subpart B. In addition, pursuant to 40 CFR 721.20, any persons who export or intend to export a chemical substance that is the subject of this proposed rule on or after September 13, 2019 are subject to the export notification provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) and must comply with the export notification requirements in 40 CFR part 707, subpart D.
EPA is proposing these SNURs under TSCA section 5(a)(2) for 17 chemical substances which were the subjects of PMNs P-16-92, P-17-346, P-17-347/348/349/350/351/352, P-17-395, P-18-35, P-18-103, P-18-155/156, P-18-286, P-18-392, P-19-29, and P-19-62. These proposed SNURs would require persons who intend to manufacture or process any of these chemical substances for an activity that is designated as a significant new use to notify EPA at least 90 days before commencing that activity.
The record for the proposed SNURs on these chemicals was established as docket EPA-HQ-OPPT-2019-0442. That record includes information considered by the Agency in developing these proposed SNURs.
Section 5(a)(2) of TSCA (15 U.S.C. 2604(a)(2)) authorizes EPA to determine that a use of a chemical substance is a “significant new use.” EPA must make this determination by rule after considering all relevant factors, including the four TSCA section 5(a)(2) factors listed in Unit III. Once EPA determines through rulemaking that a use of a chemical substance is a significant new use, TSCA section 5(a)(1)(B)(i) (15 U.S.C. 2604(a)(1)(B)(i)) requires persons to submit a significant new use notice (SNUN) to EPA at least 90 days before they manufacture or process the chemical substance for that use. TSCA prohibits such manufacturing or processing from commencing until EPA has conducted a review of the SNUN, made an appropriate determination on the SNUN, and taken such actions as are required in association with that determination (15 U.S.C. 2604(a)(1)(B)(ii)). In the case of a determination other than not likely to present unreasonable risk, the applicable review period must also expire before manufacturing or processing for the new use may commence. As described in Unit V., the general SNUR provisions are found at 40 CFR part 721, subpart A.
In determining what would constitute a significant new use for the chemical substances that are the subject of these SNURs, EPA considered relevant information about the toxicity of the chemical substances, and potential human exposures and environmental releases that may be associated with the conditions of use of the substances, in the context of the four bulleted TSCA section 5(a)(2) factors listed in this unit. During its review of these chemicals, EPA identified certain conditions of use that are not intended by the submitters, but reasonably foreseen to occur. EPA is Start Printed Page 40373proposing to designate those reasonably foreseen conditions of use as significant new uses.
EPA is proposing significant new use and recordkeeping requirements for 17 chemical substances in 40 CFR part 721, subpart E. In this unit, EPA provides the following information for each chemical substance:
Chemical name: Polymeric polyamine (generic).
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as industrial coatings, open non-dispersive use. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for irritation, corrosion, sensitization and lung effects (based on cationic binding to lung tissues), and toxicity to aquatic organisms at surface water concentrations exceeding 10 ppb, if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
Use of the PMN substance for other than for the confidential use described in the PMN.
Potentially useful information: EPA has determined that certain information about the human health and environmental toxicity of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of sensitization and environmental toxicity testing and pulmonary effects would help characterize the potential health and environmental effects of the PMN substance.
CFR citation: 40 CFR 721.11330.
Chemical name: Triarylalkyl phosphonium halide salt (generic).
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as a destructive use. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for Acute toxicity, irritation/corrosion effects to the skin, eyes, and respiratory tract, systemic toxicity, and environmental toxicity if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
1. Use for other than the confidential uses identified in the PMN.
2. Release of the PMN substance into the waters of the United States resulting in surface water concentrations exceeding 5 ppb.
Potentially useful information: EPA has determined that certain information about the human health and environmental toxicity of the PMN substance may be potentially useful to characterize the health and environmental effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of acute toxicity, specific target organ toxicity, irritation, and environmental toxicity testing would help characterize the potential health and environmental effects of the PMN substance.
CFR citation: 40 CFR 721.11331.
Chemical names: Oxirane, 2-methyl-, polymer with oxirane, mono(2-butyloctyl) ether (P-17-347); Oxirane, 2-methyl-, polymer with oxirane, mono(2-hexyldecyl) ether (P-17-348); Oxirane, 2-methyl-, polymer with oxirane, mono(2-octyldodecyl) ether (P-17-349); Oxirane, 2-methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether (P-17-350); Oxirane, 2-methyl-, polymer with oxirane, mono(2-dodecylhexadecyl) ether (P-17-351); Oxirane, 2-methyl-, polymer with oxirane, mono(2-tetradecyloctadecyl) ether (P-17-352).
CAS numbers: 252756-20-0 (P-17-347); 125005-52-9 (P-17-348); 102640-Start Printed Page 4037444-8 (P-17-349); 72484-69-6 (P-17-350); 102640-42-6 (P-17-351); and 102640-46-0 (P-17-352).
Basis for action: The PMNs state that the generic (non-confidential) use of the substances will be as an oilfield surfactant. Based on the physical/chemical properties of the PMN substances and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for lung toxicity and toxicity to aquatic organisms, if the chemical substances are used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substances that EPA intends to assess before they occur include the following:
1. Use of the PMN substances other than for the confidential use described in the PMNs.
2. Any manufacture, processing or use of the PMN substances that results in inhalation exposure.
3. Annual production volume exceeding 5,000 kilograms of the PMN substances in aggregate.
Potentially useful information: EPA has determined that certain information about the human health and environmental toxicity of the PMN substances may be potentially useful to characterize the health and environmental effects of the PMN substances if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of pulmonary effects and environmental toxicity testing would help characterize the potential health and environmental effects of the PMN substances.
CFR Citations: 40 CFR 721.11332 (P-17-347), 40 CFR 721.11333 (P-17-348), 40 CFR 721.11334 (P-17-349), 40 CFR 721.11335 (P-17-350), 40 CFR 721.11336 (P-17-351), and 40 CFR 721.11337 (P-17-352).
Chemical name: Alkyl tri dithiocarbamate tri salt (generic).
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as a water treatment additive. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for developmental toxicity, neurotoxicity, carcinogenicity, and skin sensitization, and toxicity to aquatic organisms, if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
1. Use of the PMN substance other than for the confidential uses described in the PMN.
2. Any manufacture, processing or use of the PMN substance that results in inhalation exposure.
3. Release to the PMN substance into the waters of the United States resulting in surface water concentrations exceeding 1 ppb.
Potentially useful information: EPA has determined that certain information about the human health and environmental toxicity of the PMN substance may be potentially useful to characterize the health and environmental effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of skin sensitization, reproductive/developmental toxicity, specific target organ toxicity, and environmental toxicity testing would help characterize the potential health and environmental effects of the PMN substance.
CFR citation: 40 CFR 721.11338.
Chemical name: Methacrylic acid heterocyclic alkyl ester (generic).
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as a monomer for polymer applications. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for skin and eye irritation and reproductive/developmental toxicity if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
Uses other than the confidential uses identified in the PMN.
Potentially useful information: EPA has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of genetic toxicology testing would help characterize the potential health effects of the PMN substance.
CFR citation: 40 CFR 721.11339.
Chemical name: Alkylnitrile imidazole (generic).
Basis for action: The PMN states that the use of the substance will be as an intermediate for amine manufacture. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for eye irritation, reproductive/developmental toxicity, and specific target organ toxicity if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
1. Use for other than an intermediate for amine manufacture.
Potentially useful information: EPA has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of specific target organ toxicity, reproductive/developmental toxicity, and eye irritation testing would help characterize the potential health effects of the PMN substance.
CFR citation: 40 CFR 721.113340.
Chemical names: Crosslinked polymer of alkyl acrylamides, acrylate esters, and alkyl acrylamide sulfonate salt (generic).
Basis for action: The PMNs state that the generic (non-confidential) use of the substance will be as a component in cement. Based on the physical/chemical properties of the PMN substances and Structure Activity Relationships (SAR) analysis of test data on analogous Start Printed Page 40375substances, EPA has identified concerns for lung effects and carcinogenicity if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substances that EPA intends to assess before they occur include the following:
1. Use of the PMN substances other than for the confidential uses described in the PMNs.
2. Manufacture (including import) of the PMN substances with greater than 10% of particles <10 microns.
Potentially useful information: EPA has determined that certain information about the human health toxicity of the PMN substances may be potentially useful to characterize the health effects of the PMN substances if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of pulmonary effects testing would help characterize the potential health effects of the PMN substances.
CFR citation: 40 CFR 721.11341 (P-18-155 and P-18-156).
Chemical name: Propane, 1,1,1,3,3,3-hexafluoro-2-methoxy-.
CAS number: 13171-18-1.
Basis for action: The PMN states that the use of the substance will be as solvent in vapor degreasing/vapor cleaning and other confidential uses generically described as heat transfer fluid and additive contained/sealed in low voltage electronics. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for irritation and developmental neurotoxicity effects, if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
1. Use of the PMN substance other than as a solvent in vapor degreasing/vapor cleaning or additional confidential uses described in the PMN.
2. Manufacture (including import), processing or use of the PMN substance without the transport container loading process described in the PMN.
Potentially useful information: EPA has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of skin irritation and developmental neurotoxicity testing would help characterize the potential health effects of the PMN substance.
CFR citation: 40 CFR 721.11342.
Chemical name: Heteromonocycle, alkenyl alkyl (generic).
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as an intermediate chemical. Based on the physical/chemical properties of and test data on the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for irritation/corrosion and carcinogenicity if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
No use other than the confidential uses identified in the PMN.
Potentially useful information: EPA has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of absorption, skin and eye irritation/corrosion, and carcinogenicity testing would help characterize the potential health effects of the PMN substance.
CFR citation: 40 CFR 721.11343.
Chemical name: Phosphonium, tributylethyl-, diethyl phosphate (1:1).
CAS number: 20445-94-7.
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as a catalyst. Based on the physical/chemical properties of and available data on the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for irritation, corrosion, neurotoxicity, reproductive toxicity, liver toxicity, and toxicity to aquatic organisms at surface water concentrations exceeding 51 ppb, if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
2. Release to the PMN substance into the waters of the United States resulting in surface water concentrations exceeding 51 ppb.
Potentially useful information: EPA has determined that certain information about the human health and environmental fate of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of irritation, specific target organ toxicity, neurotoxicity, and reproductive toxicity, and environmental fate testing would help characterize the potential health and environmental effects of the PMN substance.
CFR citation: 40 CFR 721.11344.
Chemical name: Hydrochlorofluoroolefin (generic).
Basis for action: The PMN states that the generic (non-confidential) use of the substance will be as an industrial solvent. Based on the physical/chemical properties of the PMN substance and Structure Activity Relationships (SAR) analysis of test data on analogous substances, EPA has identified concerns for neurotoxicity, systemic toxicity, reproductive toxicity, and lung effects if the chemical substance is used in ways other than as intended by the PMN submitter. Other conditions of use of the PMN substance that EPA intends to assess before they occur include the following:
Use other than for the confidential uses identified in the PMN.
Potentially useful information: EPA has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the health effects of the PMN substance if a manufacturer Start Printed Page 40376or processor is considering submitting a SNUN for a significant new use that would be designated by this proposed SNUR. EPA has determined that the results of specific target organ toxicity and neurotoxicity testing would help characterize the potential health effects of the PMN substance.
CFR citation: 40 CFR 721.11345.
EPA is proposing SNURs for 17 specific chemical substances which are undergoing premanufacture review because the Agency wants to achieve the following objectives with regard to the significant new uses that would be designated in this proposed rule:
EPA would be obligated to make a determination under TSCA section 5(a)(3) regarding the use described in the SNUN, under the conditions of use. The Agency will either determine under TSCA section 5(a)(3)(C) that the significant new use is not likely to present an unreasonable risk, including an unreasonable risk to a potentially exposed or susceptible subpopulation identified as relevant by the Administrator under the conditions of use, or make a determination under TSCA section 5(a)(3) (A) or (B) and take the required regulatory action associated with the determination, before manufacture or processing for the significant new use of the chemical substance can occur.
EPA designates August 1, 2019 (date of web posting) as the cutoff date for determining whether the new use is ongoing. The objective of EPA's approach is to ensure that a person cannot defeat a SNUR by initiating a significant new use before the effective date of the final rule.
SNUN submitters should be aware that EPA will be better able to evaluate SNUNs which provide detailed information on the following:Start Printed Page 40377
This action is not subject to Executive Order 13045 (62 FR 19885, April 23, Start Printed Page 403781997), because this is not an economically significant regulatory action as defined by Executive Order 12866, and this action does not address environmental health or safety risks disproportionately affecting children.
2. Add §§ 721.11330 through 721.11345 to subpart E to read as follows:
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as polymer of polyethylene polyamine and alkanediol diglycidyl ether (PMN P-16-92) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as triarylalkyl phosphonium halide salt (PMN P-17-346) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as oxirane, 2-methyl-, polymer with oxirane, mono(2-butyloctyl) ether. (P-17-347, CASRN 252756-20-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(i) Industrial, Commercial, and consumer activities. Requirements as specified in § 721.80(j) and (s) (5,000 kilograms, aggregate of PMN substances P-17-347, P-17-348, P-17-349, P-17-350, P-17-351 and P-17-352). It is a significant new use to manufacture, process or use the PMN substances in a manner that results in inhalation exposure.
(3) Determining whether a specific use is subject to this section. The provisions Start Printed Page 40379of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as oxirane, 2-methyl-, polymer with oxirane, mono(2-hexyldecyl) ether (P-17-348, CASRN 125005-52-9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as oxirane, 2-methyl-, polymer with oxirane, mono(2-octyldodecyl) ether (P-17-349, CASRN 102640-44-8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as oxirane, 2-methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether (P-17-350, CASRN 72484-69-6) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as Oxirane, 2-methyl-, polymer with oxirane, mono(2-dodecylhexadecyl) ether (P-17-351, CASRN 102640-42-6) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as oxirane, 2-methyl-, polymer with oxirane, mono(2-tetradecyloctadecyl) ether (P-17-352, CASRN 102640-46-0) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(3) Determining whether a specific use is subject to this section. The provisions Start Printed Page 40380of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as alkyl tri dithiocarbamate tri salt (PMN P-17-395) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as methacrylic acid heterocyclic alkyl ester (PMN P-18-35) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as alkylnitrile imidazole (P-18-103) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substances generically identified as crosslinked polymer of alkyl acrylamides, acrylate esters, and alkyl acrylamide sulfonate salt (PMNs P-18-155 and P-18-156) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as propane, 1,1,1,3,3,3-hexafluoro-2-methoxy- (PMN P-18-286, CASRN 13171-18-1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as heteromonocycle, alkenyl alkyl (PMN P-18-392) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(1) Recordkeeping. Recordkeeping requirements as specified in § 721.125(a) through (c), and (i) are Start Printed Page 40381applicable to manufacturers, importers, and processors of this substance.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as phosphonium, tributylethyl-, diethyl phosphate (1:1) (PMN P-19-29, CASRN 20445-94-7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(ii) Release to water. Requirements as specified in § 721.90 (a)(4), (b)(4), and (c)(4) where N = 51.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance generically identified as hydrochlorofluoroolefin (P-19-62) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
[FR Doc. 2019-17148 Filed 8-13-19; 8:45 am]